A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia

NCT05662319 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia

Interventions

DRUG: Fitusiran
DRUG: Clotting factor concentrates (CFC) or bypassing agents (BPA)
DRUG: Antithrombin concentrate (ATIIIC)

Sponsor

Sanofi